Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:dateCreated |
1992-2-3
|
| pubmed:abstractText |
Twenty-six socially phobic outpatients were treated with clonazepam for the relief of symptoms. At evaluation, which took place after an average of 11.3 months of continuous treatment, 22 (84.6%) patients showed good improvement and 4 (14.4%) showed no improvement or were not recovered. The dose declined over time, from a peak mean of 2.1 mg/day to a mean of 0.94 mg/day at follow-up. Side effects are described, along with individual case descriptions that illustrate important aspects of the use of benzodiazepines for the treatment of social phobia.
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Nov
|
| pubmed:issn |
0160-6689
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
52 Suppl
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
16-20
|
| pubmed:dateRevised |
2004-11-17
|
| pubmed:meshHeading |
pubmed-meshheading:1757453-Adult,
pubmed-meshheading:1757453-Ambulatory Care,
pubmed-meshheading:1757453-Attitude to Health,
pubmed-meshheading:1757453-Clonazepam,
pubmed-meshheading:1757453-Drug Administration Schedule,
pubmed-meshheading:1757453-Female,
pubmed-meshheading:1757453-Follow-Up Studies,
pubmed-meshheading:1757453-Humans,
pubmed-meshheading:1757453-Male,
pubmed-meshheading:1757453-Middle Aged,
pubmed-meshheading:1757453-Phobic Disorders,
pubmed-meshheading:1757453-Psychiatric Status Rating Scales,
pubmed-meshheading:1757453-Quality of Life
|
| pubmed:year |
1991
|
| pubmed:articleTitle |
Long-term treatment of social phobia with clonazepam.
|
| pubmed:affiliation |
Psychiatry Outpatient Program, Duke University Medical Center, Durham, NC 27710.
|
| pubmed:publicationType |
Journal Article,
Case Reports
|